ChemicalBook > CAS DataBase List > Lemborexant

Lemborexant

Product Name
Lemborexant
CAS No.
1369764-02-2
Chemical Name
Lemborexant
Synonyms
E 2006;CS-2189;Dayvigo.;labradon;Lemborexant;Lemborexant API;lemborexant,E2006;E-2006 Lemborexant;Lemborexant USP/EP/BP;Lemborexant Impurity 1
CBNumber
CB72744022
Molecular Formula
C22H20F2N4O2
Formula Weight
410.42
MOL File
1369764-02-2.mol
More
Less

Lemborexant Property

Melting point:
173 - 175°C
Boiling point:
596.1±50.0 °C(Predicted)
Density 
1.347±0.06 g/cm3(Predicted)
storage temp. 
-20°C, Inert atmosphere
solubility 
DMSO (Slightly), Methanol (Slightly)
pka
12.30±0.40(Predicted)
form 
Solid
color 
White to Off-White
InChIKey
MUGXRYIUWFITCP-PGRDOPGGSA-N
SMILES
[C@@H]1(C(NC2=NC=C(F)C=C2)=O)C[C@@]1(COC1=CN=C(C)N=C1C)C1=CC=CC(F)=C1
More
Less

Safety

DEA Controlled Substances
CSCN: 2245
CAS SCH: IV
NARC: N
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Biosynth Carbosynth
Product number
FL103847
Product name
Lemborexant
Packaging
10mg
Price
$245
Updated
2021/12/16
ChemScene
Product number
CS-4320
Product name
Lemborexant
Packaging
5mg
Price
$260
Updated
2021/12/16
ChemScene
Product number
CS-4320
Product name
Lemborexant
Packaging
25mg
Price
$800
Updated
2021/12/16
Biosynth Carbosynth
Product number
FL103847
Product name
Lemborexant
Packaging
50mg
Price
$857.5
Updated
2021/12/16
AK Scientific
Product number
1887DN
Product name
Lemborexant
Packaging
10mg
Price
$380
Updated
2021/12/16
More
Less

Lemborexant Chemical Properties,Usage,Production

Description

Lemborexant is a newer orexin receptor antagonist which is submitted to US FDA for review as new drug application for the treatment of insomnia after completing two key Phase 3 studies of lemborexant – SUNRISE 1 (Study 304) and SUNRISE 2 (Study 303).

Chemical Properties

Lemborexant is a white to off-white powder that is practically insoluble in water.

Uses

Lemborexant is a novel orexin receptor antagonist and is used in the treatment of insomnia, characterised by difficulties with sleep onset or sleep maintenance. Orexins are neuropeptides involved in regulating sleep and arousal by promoting wakefulness. Lemborexant blocks the binding of orexins A and B to their receptors 1 and 2 thereby reducing wakefulness and promoting sleep. Suvorexant is the other orexin receptor antagonist marketed in Australia for insomnia.

Pharmacokinetics

Effect of food High-fat & high-calorie meal delay Tmax & reduce Cmax
Tmax 1 to 3 hours
Half-life 17 hours (5 mg) and 19 hours (10 mg)
Metabolism primarily metabolized by CYP3A4
Excretion Urine (29%); feces (57%)

Synthesis

Synthesis route of Lemborexant

Drug interactions

Lemborexant is metabolized by CYP3A4 and is susceptible to interactions with medications such as amiodarone, amlodipine, carbamazepine, clarithromycin, diltiazem, fluoxetine and phenytoin. Lemborexant may affect other medications metabolised by CYP2B6, such as bupropion and methadone. Alcohol should be avoided: a single dose of alcohol can increase lemborexant concentrations up to 70%.

Mode of action

The mechanism of action of lemborexant in the treatment of insomnia is Blocks the binding of wake-promoting neuropeptides orexin A and orexin B to receptors OX1R and OX2R, presumed to suppress wake drive.

References

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212028s000lbl.pdf
https://www.smchealth.org/sites/main/files/file-attachments/dayvigo_for_publish.pdf?1592332002
https://www.superiorhealthplan.com/content/dam/centene/Superior/policies/pharmacy-policies/Lemborexant%20(Dayvigo)%20(CP.PMN.233)%20(PDF).pdf

Lemborexant Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Lemborexant Suppliers

Shanghai Peiling Biological Technology Co., LTD
Tel
13127581762 13127581762
Email
peilingchem@sina.com
Country
China
ProdList
554
Advantage
58
Hubei Hongfuda Biotechnology Co., Ltd.
Tel
19107255884
Email
259506217@qq.com
Country
China
ProdList
2188
Advantage
58
Hubei Paijian Biotechnology Co., Ltd
Tel
18163347313
Email
1205135340@qq.com
Country
China
ProdList
95
Advantage
58
Shandong Chenxi Pharmaceutical Co., Ltd.
Tel
+86-0531-88803416 13153166250
Fax
0531-88803416
Email
sales@chemedpharma.com
Country
China
ProdList
199
Advantage
58
Sichuan Qingmu Pharmaceutical Co., Ltd.
Tel
028-87827187 18681376319
Email
sales@eastonpharma.cn
Country
China
ProdList
66
Advantage
60
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
Tel
17702719238 18971495150;
Email
sales@sun-shinechem.com
Country
China
ProdList
1077
Advantage
64
S.Z. PhyStandard Bio-Tech. Co., Ltd.
Tel
0755-4000505016 13380397412
Fax
0755 28094224
Email
3001272453@qq.com
Country
China
ProdList
5158
Advantage
50
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Fax
(86) 21-58955996
Email
info@chemexpress.com
Country
China
ProdList
7552
Advantage
61
MedChemexpress LLC
Tel
021-58955995
Fax
609-228-5909
Email
sales@medchemexpress.cn
Country
United States
ProdList
4861
Advantage
58
Nanjing Sunlida Biological Technology Co., Ltd.
Tel
025-57798810
Fax
025-57019371
Email
sales@sunlidabio.com
Country
China
ProdList
3239
Advantage
55
More
Less

View Lastest Price from Lemborexant manufacturers

Xi an Biohorlden Industry Trade Co Ltd
Product
Lemborexant 1369764-02-2
Price
US $0.00-0.00/g
Min. Order
10g
Purity
99%
Supply Ability
50kg
Release date
2025-09-23
Shaanxi Dideu Medichem Co. Ltd
Product
Lemborexant 1369764-02-2
Price
US $0.00-0.00/G
Min. Order
1G
Purity
99%
Supply Ability
KG
Release date
2025-09-10
Shaanxi Dideu Medichem Co. Ltd
Product
Lemborexant 1369764-02-2
Price
US $0.00-0.00/G
Min. Order
1G
Purity
99%
Supply Ability
KG
Release date
2025-09-10

1369764-02-2, LemborexantRelated Search:


  • (1R,2S)-2-[[(2,4-Dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)cyclopropanecarboxamide
  • E 2006
  • (1R,2S)-2-[(2,4-DIMETHYLPYRIMIDIN-5-YL)OXYMETHYL]-2-(3-FLUOROPHENYL)-N-(5-FLUOROPYRIDIN-2-YL)CYCLOPROPANE-1-CARBOXAMIDE
  • lemborexant / E-2006, CID 56944144
  • Lemborexant
  • lemborexant,E2006
  • E-2006 Lemborexant
  • 2-((1S,2S)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)cyclopropyl)-N-(5-fluoropyridin-2-yl)acetamide
  • CS-2189
  • Dayvigo.
  • E-2006; E 2006; E2006; LEMBOREXANT; DAYVIGO.
  • Cyclopropanecarboxamide, 2-[[(2,4-dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)-, (1R,2S)-
  • Lemborexant USP/EP/BP
  • Lemborexant API
  • labradon
  • (1S,2R)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-1-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide
  • Lemborexant Impurity 1
  • (1R,2S)-2-[[(2,4-dimethyl-5-pyrimidine)oxy]methyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridyl)cyclopropaneformamide (Leborethen)
  • 1369764-02-2
  • API
  • 1369764-02-2